Ocular Therapeutix's total assets for Q1 2026 were $732.53M, a decrease of -9.35% from the previous quarter. OCUL total liabilities were $150.96M for the fiscal quarter, a -1.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.